Jump to content


New study works to improve physician adherence to CML treatment guidelines

  • Please log in to reply
No replies to this topic

#1 GerryL


    New Member

  • Members
  • Pip
  • 0 posts

Posted 12 June 2014 - 01:12 AM

Bone marrow transplants or chemotherapy were once the only treatment options available for chronic myeloid leukemia (CML), a rare blood cancer. Until recently, survival rates weren't remarkable; but new tyrosine kinase inhibitor medications, like imatinib, dasatinib and nilotinib, have transformed CML treatment—patients are now living full lives thanks to targeted therapy. http://www.coloradoc...ent-guidelines/

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users